Incyte Corp. (INCY)
121.47
-1.81
(-1.47%)
USD |
NASDAQ |
Sep 11, 16:00
121.75
+0.28
(+0.23%)
After-Hours: 20:00
Incyte Price to Book Value : 3.848 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 3.848 |
| September 10, 2026 | 3.905 |
| September 09, 2026 | 3.992 |
| September 08, 2026 | 3.941 |
| September 04, 2026 | 4.015 |
| September 03, 2026 | 4.055 |
| September 02, 2026 | 4.081 |
| September 01, 2026 | 3.96 |
| August 31, 2026 | 3.903 |
| August 28, 2026 | 3.940 |
| August 27, 2026 | 4.046 |
| August 26, 2026 | 4.059 |
| August 25, 2026 | 4.109 |
| August 24, 2026 | 4.054 |
| August 21, 2026 | 4.049 |
| August 20, 2026 | 4.030 |
| August 19, 2026 | 4.070 |
| August 18, 2026 | 3.911 |
| August 17, 2026 | 3.912 |
| August 14, 2026 | 3.806 |
| August 13, 2026 | 3.818 |
| August 12, 2026 | 3.826 |
| August 11, 2026 | 3.835 |
| August 10, 2026 | 3.850 |
| August 07, 2026 | 3.819 |
| Date | Value |
|---|---|
| August 06, 2026 | 3.75 |
| August 05, 2026 | 3.795 |
| August 04, 2026 | 3.820 |
| August 03, 2026 | 3.752 |
| July 31, 2026 | 3.786 |
| July 30, 2026 | 3.896 |
| July 29, 2026 | 4.026 |
| July 28, 2026 | 4.116 |
| July 27, 2026 | 3.766 |
| July 24, 2026 | 3.728 |
| July 23, 2026 | 3.696 |
| July 22, 2026 | 3.668 |
| July 21, 2026 | 3.719 |
| July 20, 2026 | 3.664 |
| July 17, 2026 | 3.714 |
| July 16, 2026 | 3.695 |
| July 15, 2026 | 3.646 |
| July 14, 2026 | 3.639 |
| July 13, 2026 | 3.619 |
| July 10, 2026 | 3.697 |
| July 09, 2026 | 3.754 |
| July 08, 2026 | 3.714 |
| July 07, 2026 | 3.740 |
| July 06, 2026 | 3.663 |
| July 02, 2026 | 3.702 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Mirum Pharmaceuticals, Inc. | -- |
| Regeneron Pharmaceuticals, Inc. | 2.548 |
| AbbVie, Inc. | -- |
| Biogen, Inc. | 1.702 |
| Eli Lilly & Co. | 31.01 |
Price to Book Value Related Metrics
| PE Ratio | 15.48 |
| PS Ratio | 4.285 |
| PEG Ratio | 0.1975 |
| Price to Free Cash Flow | 13.19 |
| Price | 121.47 |
| Earnings Yield | 6.46% |
| Market Cap | 24.41B |
| PEGY Ratio | 0.1975 |
| Operating PE Ratio | 13.56 |
| Normalized PE Ratio | 15.24 |